{"result": "(\"entity\"<|>NEUROENDOCRINE TUMOR SOCIETY<|>ORGANIZATION<|>The Neuroendocrine Tumor Society is an organization focused on the diagnosis and management of neuroendocrine tumors.)\n##\n(\"entity\"<|>AMERICAN THYROID ASSOCIATION<|>ORGANIZATION<|>The American Thyroid Association is an organization that provides guidelines for the management of thyroid conditions, including thyroid cancer.)\n##\n(\"entity\"<|>GETC STUDY GROUP<|>ORGANIZATION<|>The GETC Study Group is a research group that studies medullary thyroid carcinoma and its prognostic factors.)\n##\n(\"entity\"<|>MEDULLARY THYROID CARCINOMA<|>EVENT<|>Medullary thyroid carcinoma is a type of thyroid cancer that is addressed in various clinical guidelines and studies.)\n##\n(\"entity\"<|>THYROID CANCER<|>EVENT<|>Thyroid cancer is a condition that is diagnosed and managed according to guidelines set by organizations like the American Thyroid Association.)\n##\n(\"entity\"<|>Haugen BR<|>PERSON<|>Haugen BR is an author of the American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.)\n##\n(\"entity\"<|>Wells SA<|>PERSON<|>Wells SA is a contributor to the guidelines for the management of medullary thyroid carcinoma.)\n##\n(\"relationship\"<|>NEUROENDOCRINE TUMOR SOCIETY<|>GETC STUDY GROUP<|>Both organizations focus on the diagnosis and management of tumors, specifically neuroendocrine and thyroid tumors.<|>3)\n##\n(\"relationship\"<|>AMERICAN THYROID ASSOCIATION<|>GETC STUDY GROUP<|>Both organizations provide guidelines and research on thyroid cancer management, including medullary thyroid carcinoma.<|>4)\n##\n(\"relationship\"<|>GETC STUDY GROUP<|>MEDULLARY THYROID CARCINOMA<|>The GETC Study Group conducts research specifically on medullary thyroid carcinoma.<|>5)\n##\n(\"relationship\"<|>AMERICAN THYROID ASSOCIATION<|>MEDULLARY THYROID CARCINOMA<|>The American Thyroid Association provides guidelines for the management of medullary thyroid carcinoma.<|>5)\n##\n(\"relationship\"<|>Haugen BR<|>AMERICAN THYROID ASSOCIATION<|>Haugen BR is an author of the guidelines published by the American Thyroid Association.<|>6)\n##\n(\"relationship\"<|>Wells SA<|>AMERICAN THYROID ASSOCIATION<|>Wells SA is a contributor to the guidelines published by the American Thyroid Association.<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors:                      Sin embargo, la opción B es verdadera. En efecto, la captación en una PET 18F-FDG en pa-\n       pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas. 2010;39:775-83.                                                  cientes con carcinoma diferenciado de tiroides metastásico es un factor predictivo negati-\n     • Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, et al. Point mutation within the tyrosine kinase domain of the RET          vo de la respuesta al tratamiento con I-131 y un factor pronóstico independiente de supervi-\n       proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet. 1994;3:237-41.\n     • Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab.      vencia. Así, en una serie de 400 pacientes con carcinoma diferenciado de tiroides a quienes\n     • 2010;95:2655-63.\n       Marx SJ, Wells SA. Multiple Endocrine Neoplasia. Cap. 41. 12.ª ed, Williams. Textbook of Endocrinology. p. 1753.                          en su seguimiento se había efectuado PET 18F-FDG, únicamente la edad y una captación\n     • Modigliani E, Cohen R, Campos JM, Conte-Devolx B, Maes B, Boneu A, et al. Prognostic factors for survival and for biochemical cure        positiva en la PET 18F-FDG fueron predictores de supervivencia en el análisis multivariante.\n       in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d’etude des tumeurs a calcitonine. Clin\n       Endocrinol (Oxf). 1998;48:265-73.\n     • Wells SA, Asa SL, Dralle H, Elisei R, Evan DB, Gagel RF, et al. Revised American Thyroid Association Guidelines for the Management\n       of Medullary Thyroid Carcinoma. The American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Thyroid.\n       2015;25(6):567-610.\n\n\n\n182                                                                                                                                                                                                                                                     183\n---\n                                                                                                                                                                                                                                                                 TIROIDES                           3\n\n\n\n               Finalmente, la última opción es falsa. La sensibilidad de la PET 18F-FDG para detectar posibles                                          3.8 Casos clínicos. Caso clínico 1\n               metástasis de estos tumores aumenta con el estímulo con TSH. En el estudio de Lebou-\n               lleux et al., en el que se realizó PET              18F-FDG antes         y después      de un estímulo         con TSHrh       a\n               63 pacientes con cáncer diferenciado de tiroides y Tg elevadas, encontraron un total de                                                     46      Según      la 8.ª versión       de la clasificación TNM de la AJCC (American Joint                              Committee\n               108    lesiones en 48 órganos en 30 de estos pacientes. La PET estimulada detectó el 95%                                                            on   Cancer), este paciente             ha de clasificarse como:\n               de estas lesiones, frente al           81% de la      PET basal (p = 0,001).\n               Referencias:                                                                                                                                        A. T3 N1 M0 Estadio II.\n               • Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management                       B. T2 N1a M0 Estadio I.\n                 Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines\n                 Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1-133.                                                          C. T3 N1a M0 Estadio III.\n               • Robbins RJ, Wan Q, Grewal RK, Reibke R, Gonen M, Strauss HW, et al. Real-time prognosis for metastatic thyroid carcinoma based                    D.  T3a N1a M0 Estadio II.\n                 on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab. 2006;91:498-505.\n               • Deandreis D, Al Ghuzlan A, Leboulleux S, Lacroix L, Garsi JP, Talbot M, et al. Do histological, immunohistochemical, and metabolic\n                 (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome? Endocr Relat\n                 Cancer. 2011;18:159-69.                                                                                                                           COMENTARIO\n               • Leboulleux S, Schroeder PR, Busaidy NL, Auperin A, Corone C, Jacene HA, et al. Assessment of the incremental value of recombinant\n                 thyrotropin stimulation before 2-[18F]-fluoro\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}